Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares traded up 16.4% on Wednesday . The stock traded as high as GBX 1.63 and last traded at GBX 1.63. 485,718 shares changed hands during mid-day trading, a decline of 29% from the average session volume of 687,415 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Price Performance
The stock has a market cap of £6.46 million, a PE ratio of -5.09 and a beta of 0.38. The stock has a 50-day simple moving average of GBX 1.62 and a 200-day simple moving average of GBX 1.54.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Read More
- Five stocks we like better than Cizzle Biotechnology
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump Planning to Use Public Law 63-43: Prepare Now
- A month before the crash
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
